3.550
+0.210
+(6.29%)
As of 9:55:51 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,187,468
1,187,468
1,264,073
1,570,129
1,637,970
Cost of Revenue
286,452
286,452
236,414
275,429
283,882
Gross Profit
901,016
901,016
1,027,659
1,294,700
1,354,088
Operating Expense
1,351,716
1,351,716
1,408,745
1,898,162
868,901
Operating Income
-450,700
-450,700
-381,086
-603,462
485,187
Net Non Operating Interest Income Expense
-33,125
-33,125
-14,999
74
-5,005
Pretax Income
-2,270,645
-2,270,645
-434,165
-606,703
485,886
Tax Provision
-320,404
-320,404
-203,535
69,170
85,472
Net Income Common Stockholders
-1,301,005
-1,301,005
-319,601
-692,774
379,287
Diluted NI Available to Com Stockholders
-1,301,005
-1,301,005
-319,601
-692,774
379,287
Basic EPS
-1.07
-1.07
-0.27
-0.57
0.31
Diluted EPS
-1.07
-1.07
-0.27
-0.57
0.31
Basic Average Shares
1,211,062.599
1,211,062.599
1,202,506.770
1,209,713.999
1,209,713.999
Diluted Average Shares
1,211,062.599
1,211,062.599
1,202,506.770
1,209,713.999
1,209,713.999
Rent Expense Supplemental
--
--
2,868
2,881
1,246
Total Expenses
1,638,168
1,638,168
1,645,159
2,173,591
1,152,783
Net Income from Continuing & Discontinued Operation
-1,301,005
-1,301,005
-319,601
-692,774
379,287
Normalized Income
441,012.017
441,012.017
-301,495.250
-688,043
380,700.984
Interest Income
10,707
10,707
10,694
10,777
10,736
Interest Expense
43,832
43,832
25,693
10,703
15,741
Net Interest Income
-33,125
-33,125
-14,999
74
-5,005
EBIT
-2,226,813
-2,226,813
-408,472
-596,000
501,627
EBITDA
-2,052,116
-2,052,116
-242,031
-451,709
629,969
Reconciled Cost of Revenue
286,452
286,452
236,414
275,429
283,882
Reconciled Depreciation
174,697
174,697
166,441
144,291
128,342
Net Income from Continuing Operation Net Minority Interest
-1,301,005
-1,301,005
-319,601
-692,774
379,287
Total Unusual Items Excluding Goodwill
-1,782,030
-1,782,030
-24,141
-6,308
-1,716
Total Unusual Items
-1,570,586
-1,570,586
-24,141
-6,308
-1,716
Normalized EBITDA
-481,530
-481,530
-217,890
-445,401
631,685
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-251,456.983
-251,456.983
-6,035.250
-1,577
-302.016
12/31/2020 - 10/6/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6978.HK Immunotech Biopharm Ltd
3.810
+7.00%
9969.HK InnoCare Pharma Limited
8.410
+6.32%
2257.HK Sirnaomics Ltd.
3.110
+4.36%
1877.HK JUNSHI BIO
13.900
+6.11%
6826.HK Shanghai Haohai Biological Technology Co., Ltd.
24.450
+4.94%
2511.HK HighTide Therapeutics, Inc.
1.390
+2.96%
2197.HK Clover Biopharmaceuticals, Ltd.
0.205
+2.50%
2157.HK Lepu Biopharma Co., Ltd.
3.580
+6.23%
1244.HK 3D MEDICINES
3.660
+10.51%
9966.HK Alphamab Oncology
6.270
+8.48%